Journal Guide

In the past decade research into skin pharmacology has developed dramatically with new and promising drugs and therapeutic concepts being introduced regularly. Recent examples include immunosuppressive topicals, and new strategies in the therapy of malignant melanoma and wound healing. New concepts have also been developed in traditional areas of skin therapy and skin care which have led to discussions of issues such as ‘cosmeceuticals’ in the United States, ‘quasi-drugs’ in Japan, and the 6th Amendment of the Cosmetic Regulation in the European Union. There are many open questions which reflect the importance of the subject and the need for a new international scientific forum where they can be discussed in extenso. Dermatologists, pharmaceutical chemists, pharmacologists, toxicologists, and others interested in the subject are invited to contribute to this exciting project and to submit their best research work for publication.

Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome. Articles should include demonstrable evidence of the usefulness of this methodology (presumably by means of an application).

The Editorial Board of SBR intends to ensure that the journal continually provides important, useful, and timely information. To accomplish this, the board strives to attract outstanding articles by seeing that each submission receives a careful, thorough, and prompt review.

Steroids is an international journal devoted to original research on all aspects of steroids. Its focus is on both experimental and theoretical studies in chemistry and physiochemistry, biosynthesis, metabolism, molecular biology, physiology, pharmacology, analytical techniques, comparative endocrinology, clinical research, mode of action (including that of related peptides), and the role of steroids on growth and differentiation.Please bookmark this URL: http://www.elsevier.com/locate/steroidsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Sustainable Chemistry and Pharmacy is an international journal suitable for the publication of original communications as well as review articles. In this it has a wide general appeal and accepts the full spectrum of high quality manuscripts from short communications to extended research papers as well as review articles. Papers describing new concepts or contributing to a better understanding of concepts related to sustainable chemistry and pharmacy are highly welcome. Papers should be of originality, novelty and uniqueness. A short communication should present a novel finding that warrants immediate publication.

All manuscripts must be written so as to be widely accessible and understandable to interdisciplinary and trans disciplinary oriented readers without neglecting the disciplinary excellence and clearness.

Sustainable Chemistry and Pharmacy does not publish research associated with 'end-of-pipe' or remediation issues, if they are not clearly related to sustainability.

Letters to the editor and discussion papers are welcome in order to provide a forum for discussions on a high scientific level. Additionally, a news section provides an interesting variety of news, facts, forthcoming events and conferences as well as book reviews.

Tetrahedron publishes experimental and theoretical research results of outstanding significance and timeliness in the field of organic chemistry and its application to related disciplines especially bio-organic chemistry. Areas covered by the journal include the many facets of organic synthesis, organic reactions, natural products chemistry, studies of reaction mechanism and various aspects of spectroscopy. Contributions take the form of full papers, which are major original contributions to the literature. Tetrahedron also publishes specially commissioned review articles - Tetrahedron Reports - and collections of original papers - Tetrahedron Symposia-in-Print.Comments and Proposals: Elsevier also publishes books in this area. If you have a suggestion for a book topic or would like to submit a book proposal, please contact us at: chemistry@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Tetrahedron Letters provides maximum dissemination of outstanding developments in organic chemistry. The journal is published weekly and covers developments in techniques, structures, methods and conclusions in experimental and theoretical organic chemistry. Rapid publication of timely and significant research results enables researchers from all over the world to transmit quickly their new contributions to large, international audiences.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The AAPS Journal is an online-only journal publishing peer-reviewed scholarly reviews, themed issues and research articles within the entire scope of the pharmaceutical sciences encompassed by the AAPS membership. The Journal particularly aims to foster the dissemination of scientific information presented at AAPS-sponsored meetings, workshops and symposia, through the publication of invited reviews in themed issues. Additionally, guest editors are invited to organize special themed issues on scientific subjects of current interest. Submission of uninvited expert reviews and research articles in all areas of pharmaceutical sciences are welcomed, although manuscripts focused on pharmaceutical formulation, technology and engineering should be directed to our sister e-journal, AAPS PharmSciTech. The AAPS Journal publishes four issues a year.

The Journal of Antibiotics seeks to promote research on antibiotics and related types of medicinal substances. The journal will accept biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal's scope. Contributions regarding antibiotics and bioactive microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below: * Discovery of new antibiotics and related microbial products * Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related microbial products * Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related microbial products * Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related microbial products * Newly found properties, mechanisms of action and resistance-development of antibiotics and related microbial productsThe Journal of Antibiotics's original articles cover new theories and primary research. The journal also publishes regular short reviews, book reviews, and news and commentary articles.

For more than 50 years, clinical pharmacologists, clinical and pharmaceutical researchers, drug development specialists, physicians, nurses, and other medical professionals have relied on The Journal of Clinical Pharmacology (JCP) for original research, special reviews, commentaries, and case reports on all phases of drug development from absorption, disposition, metabolism, excretion interactions, and preferred uses through post-marketing evaluations.

The Journal of Gene Medicine publishes high quality original articles and reviews on the science of gene transfer and its applications in gene and cell therapy. Key areas of interest are the design and production of vectors, delivery and targeting, gene expression and regulation, preclinical studies including animal models, developmental aspects and clinical trials. The editors particularly welcome articles dealing with the methodological aspects of gene transfer in vivo, notably in the context of human studies. Papers presenting research into the mechanisms underlying gene transfer; the application and refinement of new technologies such as RNAi, stem cells and allied approaches such as DNA vaccines; or addressing more fundamental biological issues which could lead to more effective gene transfer are also encouraged. Please note that the Journal of Gene Medicine is online-only.

A leading research journal in the field of pharmacology published since 1909, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.

The Natural Products Journal publishes original research articles, reviews, letters and guest edited issues on all aspects of research and development in the field including: isolation, purification, structure elucidation, synthesis and bioactivity of chemical compounds found in nature.

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.Key areas of coverage include: * Personalized medicine * Effects of genetic variability on drug toxicity and efficacy * Identification and functional characterization of polymorphisms relevant to drug action * Pharmacodynamic and pharmacokinetic variations and drug efficacy * Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics * Clinical applications of genomic science * Identification of novel genomic targets for drug development * Potential benefits of pharmacogenomics.

Therapeutic Advances in Neurological Disorders is aimed at clinicians and researchers in neurology and is a forum for presenting the latest research and reviews in this discipline, concentrating on the more-common non-cerebrovascular neurological disorders. Topics covered include: neuroimmunology; movement and neurodegenerative disorders; pain and headache; behavioral cognitive syndromes; infections and neoplasms; demyelinating diseases such as multiple sclerosis; disorders and injuries to the brain and spinal cord; epilepsy/seizure disorders.

In a highly competitive industry, Therapeutic Delivery provides the busy researcher with a forum for the rapid publication of original research and critical reviews of all the latest relevant and significant developments, and focuses on how the technological, pharmacological, clinical and physiological aspects come together to successfully deliver modern therapeutics to patients. The journal delivers this essential information in concise, at-a-glance article formats that are readily accessible to the full spectrum of therapeutic delivery researchers.

Therapeutic Drug Monitoring is an outstanding journal that fosters the exchange of knowledge among the various disciplines--clinical pharmacology, pathology, toxicology, analytical chemistry--that share a common interest in therapeutic drug monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs; original articles; case reports; technical notes; and continuing education articles.Published BiMonthlyWebsite: www.drug-monitoring.com.